A cytokine study in children and adolescents with Tourette's disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 6, 2009, Pages 967-971

  Gabbay, Vilma ^a   Coffey, Barbara J ^a   Guttman, Leah E ^a   Gottlieb, Lev ^a   Katz, Yisrael ^a   Babb, James S ^b   Hamamoto, Mia M ^a   Gonzalez, Charles J ^b  

^a NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Interleukin 12; Interleukin 2; Obsessive compulsive disorder; Tourette's disorder

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; CLONIDINE; CYTOKINE; FLUOXETINE; FLUVOXAMINE; GUANFACINE; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; METHYLPHENIDATE; OLANZAPINE; PAROXETINE; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; RISPERIDONE; SERTRALINE; TUMOR NECROSIS FACTOR ALPHA; VENLAFAXINE;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; IMMUNE SYSTEM; MALE; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; OPPOSITIONAL DEFIANT DISORDER; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SEPARATION ANXIETY; STATISTICAL ANALYSIS;

ADOLESCENT; AGE FACTORS; CHILD; COHORT STUDIES; FEMALE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-2; MALE; OBSESSIVE-COMPULSIVE DISORDER; TOURETTE SYNDROME; YOUNG ADULT;

EID: 67651093937     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.05.001     Document Type: Article

References (34)

1. Bloch M.H., Landeros-Weisenberger A., Kelmendi B., Coric V., Bracken M.B., and Leckman J.F. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 11 (2006) 622-632
2. Brambilla F., Perna G., Bellodi L., Arancio C., Bertani A., Perini G., et al. Plasma interleukin-1 beta and tumor necrosis factor concentrations in obsessive-compulsive disorders. Biol Psychiatry 42 (1997) 976-981
3. Brebner K., Hayley S., Zacharko R., Merali Z., and Anisman H. Synergistic effects of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha: central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology 22 (2000) 566-580
4. Coffey B.J., Miguel E.C., Biederman J., Baer L., Rauch S.L., O'Sullivan R.L., et al. Tourette's disorder with and without obsessive-compulsive disorder in adults: are they different?. J Nerv Ment Dis 186 (1998) 201-206
5. Comabella M., Balashov K., Issazadeh S., Smith D., Weiner H.L., and Khoury S.J. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J Clin Invest 102 (1998) 671-678
6. De Sarro G.B., Masuda Y., Ascioti C., Audino M.G., and Nistico G. Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone. Neuropharmacology 29 (1990) 167-179
7. Denys D., Fluitman S., Kavelaars A., Heijnen C., and Westenberg H. Decreased TNF-alpha and NK activity in obsessive-compulsive disorder. Psychoneuroendocrinology 29 (2004) 945-952
8. Gabbay V., Klein R., Alonso C., Babb J.S., Nishawala M., De Jesus G., et al. Immune system dysregulation in adolescent major depressive disorder. J Affect Disord 115 1-2 (2009) 177-182
9. Genain C.P., Cannella B., Hauser S.L., and Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 5 (1999) 170-175
10. Giedd J.N., Rapoport J.L., Garvey M.A., Perlmutter S., and Swedo S.E. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am J Psychiatry 157 (2000) 281-283
11. Huang Y., Li T., Wang Y., Ansar J., Lanting G., Liu X., et al. Linkage disequilibrium analysis of polymorphisms in the gene for myelin oligodendrocyte glycoprotein in Tourette's syndrome patients from a Chinese sample. Am J Med Genet B Neuropsychiatr Genet 124B (2004) 76-80
12. Kaufman J., Birmaher B., Brent D., Rao U., Flynn C., Moreci P., et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psych 36 (1997) 980-988
13. Kawikova I., Leckman J.F., Kronig H., Katsovich L., Bessen D.E., Ghebremichael M., et al. Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with Tourette syndrome: a preliminary study. Biol Psychiatry 61 (2007) 273-278
14. - T cell activation in the presence of T regulatory cells. J Immunol 175 (2005) 641-645
15. Konuk N., Tekin I.O., Ozturk U., Atik L., Atasoy N., Bektas S., et al. Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder. Mediators Inflamm (2007) 65704
16. Kronfol Z., and Remick D.G. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatr 157 (2000) 683-694
17. Kwak C., Dat Vuong K., and Jankovic J. Premonitory sensory phenomenon in Tourette's syndrome. Mov Disord 18 (2003) 1530-1533
18. Leckman J.F., Riddle M.A., Hardin M.T., Ort S.I., Swartz K.L., Stevenson J., et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28 (1989) 566-573
19. Leckman J.F., Katsovich L., Kawikova I., Lin H., Zhang H., Kronig H., et al. Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome. Biol Psychiatry 57 (2005) 667-673
20. Leslie D.L., Kozma L., Martin A., Landeros A., Katsovich L., King R.A., et al. Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children. J Am Acad Child Adolesc Psychiatry 47 10 (2008) 1166-1172
21. Luo F., Leckman J.F., Katsovich L., Findley D., Grantz H., Tucker D.M., et al. Prospective longitudinal study of children with tic disorders and/or obsessive-compulsive disorder: relationship of symptom exacerbations to newly acquired streptococcal infections. Pediatrics 113 (2004) e578-e585
22. Malek T.R. The biology of interleukin-2. Annu Rev Immunol 26 (2008) 453-479
23. Miguel E.C., Leckman J.F., Rauch S., do Rosario-Campos M.C., Hounie A.G., Mercadante M.T., et al. Obsessive-compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry 10 (2005) 258-275
24. Monteleone P., Catapano F., Fabrazzo M., Tortorella A., and Maj M. Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder. Neuropsychobiology 37 (1998) 182-185
25. Mossner R., Heils A., Stober G., Okladnova O., Daniel S., and Lesch K.P. Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6. Neurochem Int 33 (1998) 251-254
26. Murphy M.L., and Pichichero M.E. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection (PANDAS). Arch Pediatr Adolesc Med 156 (2002) 356-361
27. Pollmacher T., Haack M., Schuld A., Reichenberg A., and Yirmiya R. Low levels of circulating inflammatory cytokines-do they affect human brain functions?. Brain Behav Immun 16 (2002) 525-532
28. Scahill L., Riddle M.A., McSwiggin-Hardin M., Ort S.I., King R.A., Goodman W.K., et al. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 36 (1997) 844-852
29. Singer H.S., Gause C., Morris C., and Lopez P. Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections. Pediatrics 121 (2008) 1198-1205
30. Swedo S.E., Leonard H.L., Garvey M., Mittleman B., Allen A.J., Perlmutter S., et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 155 (1998) 264-271
31. Trinchieri G., Pflanz S., and Kastelein R.A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19 (2003) 641-644
32. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10 (1992) 411-452
33. Weizman R., Laor N., Barber Y., Hermesh H., Notti I., Djaldetti M., et al. Cytokine production in obsessive-compulsive disorder. Biol Psychiatry 40 (1996) 908-912
34. Zai G., Bezchlibnyk Y.B., Richter M.A., Arnold P., Burroughs E., Barr C.L., et al. Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 129B (2004) 64-68